These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1505 related articles for article (PubMed ID: 26715812)

  • 1. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
    Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
    Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative adjuvant treatment for gastric cancer improves long-term survival after curative resection and D2 lymphadenectomy. Results from a Latin American Center.
    Norero E; Bustos M; Herrera ME; Cerda J; González P; Ceroni M; Martínez C; Briceño E; Rojas H; Cártes R; Lopez V; Hidalgo V; Báez S; Caracci M; Viñuela E; Díaz A
    Eur J Surg Oncol; 2016 Jan; 42(1):94-102. PubMed ID: 26577767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator?
    Moriwaki Y; Kobayashi S; Kunisaki C; Harada H; Imai S; Kido Y; Kasaoka C
    Dig Surg; 2001; 18(2):111-7. PubMed ID: 11351155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open vs robot-assisted laparoscopic gastric resection with D2 lymph node dissection for adenocarcinoma: a case-control study.
    Caruso S; Patriti A; Marrelli D; Ceccarelli G; Ceribelli C; Roviello F; Casciola L
    Int J Med Robot; 2011 Dec; 7(4):452-8. PubMed ID: 21984205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there any role of additional retropancreatic lymph node dissection on D2 gastrectomy for advanced gastric cancer?
    Eom BW; Joo J; Kim YW; Park B; Park JY; Yoon HM; Lee JH; Ryu KW
    Ann Surg Oncol; 2013 Aug; 20(8):2669-75. PubMed ID: 23543195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.
    Bostanci EB; Ozer I; Ercan M; Ulas M; Koc U; Karaman K; Dalgic T; Ozogul Y; Akoglu M
    Hepatogastroenterology; 2013 May; 60(123):624-7. PubMed ID: 23635437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascularizing lymph node dissection for advanced gastric cancer: A single-institution experience.
    Han FH; Zhou SN; Li HM; He YL; Zhan WH
    World J Gastroenterol; 2016 Apr; 22(14):3813-20. PubMed ID: 27076766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Low Weight Affects Long-term Outcomes Following Curative Gastrectomy for Gastric Cancer.
    Komatsu S; Kosuga T; Kubota T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
    Anticancer Res; 2018 Sep; 38(9):5331-5337. PubMed ID: 30194185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of complication grade on survival following curative gastrectomy for carcinoma.
    Jiang N; Deng JY; Ding XW; Zhang L; Liu HG; Liang YX; Liang H
    World J Gastroenterol; 2014 Jul; 20(25):8244-52. PubMed ID: 25009399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic D2 Lymph Node Dissection During Distal Subtotal Gastrectomy for Gastric Cancer: Toward Procedural Standardization.
    Kim YM; Son T; Kim HI; Noh SH; Hyung WJ
    Ann Surg Oncol; 2016 Aug; 23(8):2409-10. PubMed ID: 26957501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical and long-term oncologic outcomes of laparoscopic and open gastrectomy for serosa-positive (pT4a) gastric cancer: A propensity score-matched analysis.
    Li Z; Liu Y; Hao Y; Bai B; Yu D; Zhao Q
    Surg Oncol; 2019 Mar; 28():167-173. PubMed ID: 30851895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.